Real-Time Clinical Trials: A Turning Point for Sponsors, Regulators, and Patients
The FDA’s announcement on real-time clinical trials marks a meaningful step forward for clinical research. By launching proof-of-concept studies with AstraZeneca and Amgen and opening an RFI for a broader pilot, the agency is signaling that faster, smarter, more connected trials are no longer theoretical. They are becoming operational. The goal is clear: reduce lag […]
More Details